ArticleCancer reports (Hoboken, N.J.)2026
Development of a Machine Learning Model for Distant Metastasis Risk Stratification in Acral Melanoma.
Article in Cancer reports (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAcral melanoma (AM) is a distinct melanoma subtype associated with delayed diagnosis, aggressive progression, and poor prognosis once distant metastasis occurs. However, prediction models specifically designed for distant metastasis risk stratification in AM remain limited.
aimsThis study aimed to develop and internally evaluate a machine learning-based model for individualized distant metastasis risk stratification in patients with AM. METHODS AND
resultsClinical data of 1822 patients with AM diagnosed between 2000 and 2021 were extracted from the SEER database. Patients were divided into training and internal test sets at a ratio of 7:3 using stratified sampling. Logistic regression analyses were performed to identify factors associated with distant metastasis, and six machine learning algorithms were developed and compared. SMOTE was applied only to the training set to address class imbalance. Multivariate logistic regression identified sentinel lymph node biopsy as an independent protective factor, whereas higher N stage and lower median household income were independent risk factors. Among the evaluated models, LightGBM showed relatively balanced overall performance and was selected as the optimal model. SHAP analysis identified N stage, sentinel lymph node biopsy record, and median household income as the most important predictors.
conclusionThe LightGBM model demonstrated moderate predictive performance for distant metastasis risk stratification in patients with AM. This model may serve as a research-oriented tool for individualized risk assessment, although external validation using independent real-world cohorts is required before clinical application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.